Search Results - "Salamero, O"

Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy by Martínez-Cuadrón, D, Montesinos, P, Vellenga, E, Bernal, T, Salamero, O, Holowiecka, A, Brunet, S, Gil, C, Benavente, C, Ribera, J M, Pérez-Encinas, M, De la Serna, J, Esteve, J, Rubio, V, González-Campos, J, Escoda, L, Amutio, M E, Arnan, M, Arias, J, Negri, S, Lowënberg, B, Sanz, M A

“…Treatment outcome in older patients with acute promyelocytic leukemia (APL) is lower compared with younger patients, mainly because of a higher induction death…”
Get full text

Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML by Nomdedéu, J F, Hoyos, M, Carricondo, M, Bussaglia, E, Estivill, C, Esteve, J, Tormo, M, Duarte, R, Salamero, O, de Llano, M P Q, García, A, Bargay, J, Heras, I, Martí-Tutusaus, J M, Llorente, A, Ribera, J M, Gallardo, D, Aventin, A, Brunet, S, Sierra, J

“…We retrospectively assessed whether normalized bone marrow WT1 levels could be used for risk stratification in a consecutive series of 584 acute myeloid…”
Get full text

Characteristics and Prognosis of Patients Diagnosed with AML and MDS Who Were Excluded from Clinical Trials. A Retrospective Single-Center Analysis by Merchan, B, Casares, V, Salamero, O, Carpio, C, Gallur, L, Molero, A, Blanco, A, Montoro, J, Tazon, B, Valcarcel, D

Get full text

P385: DETECTION OF KMT2A PARTIAL TANDEM DUPLICATIONS IN ACUTE MYELOID LEUKEMIA PATIENTS BY NGS by Artigas‐Baleri, A., Oñate, G., Brell, A., Esteve, J., Vives, S., Tormo, M., Arnan, M., Garcia, A., Coll, R., Sampol, A., Bargay, J., Vall‐llovera, F., Salamero, O., Nomdedéu, J., Pratcorona, M.

Get full text

P565: IMPROVED OUTCOME OF PATIENS WITH ACUTE MYELOID LEUKEMIA HARBORING FLT3 MUTATION IN THE ERA OF TARGETED THERAPY by Oñate, G., Pratcorona, M., Garrido, A., Artigas, A., Bataller, A., Tormo, M., Arnan, M., Vives, S., Coll, R., Salamero, O., Vall‐Llovera, F., Sampol, A., Garcia, A., Cervera, M., Garcia Avila, S., Bargay, J., Ortin, X., Esteve, J., Sierra, J.

Get full text

Adverse impact of IDH1 and IDH2 mutations in primary AML: Experience of the Spanish CETLAM group by Nomdedéu, J, Hoyos, M, Carricondo, M, Esteve, J, Bussaglia, E, Estivill, C, Ribera, J.M, Duarte, R, Salamero, O, Gallardo, D, Pedro, C, Aventin, A, Brunet, S, Sierra, J

“…Abstract The study of genetic lesions in AML cells is helpful to define the prognosis of patients with this disease. This study analyzed the frequency and…”
Get full text

P586: IADADEMSTAT COMBINATION WITH AZACITIDINE SHOWS ENCOURAGING SAFETY AND EFFICACY DATA IN ELDERLY AND UNFIT AML PATIENTS by Salamero, O., Somervaille, T., Molero, A., Acuña‐Cruz, E., Perez‐Simon, J. A., Coll, R., Arnan Sangerman, M., Merchan, B., Perez, A., Cano, I., Rodriguez‐Veiga, R., Arevalo, M., Gutierrez, S., Buesa, C., Bosch, F., Montesinos, P.

Get full text

An IPSS-R Cutoff Point of 3 Stratified Myelodysplastic Syndromes Patients Into Two Risk Groups by Montoro Gómez, J, Pomares, H, Merchán, B, Molero, A, Alonso, E, Fernández, M, Gallur, L, Grau, J, Salamero, O, Tazón-Vega, B, Blanco, A, Ortega, M, Sureda, A, Arnán, M, Valacárcel, D

Get full text

An IPSS-R Cutoff Point of 3 Stratified Chronic Myelomonocytic Leukemia Patients Into Two Risk Groups by Montoro Gómez, J, Pomares, H, Merchan, B, Molero, A, Alonso, E, Fernández, M, Gallur, L, Grau, J, Salamero, O, Tazón-Vega, B, Blanco, A, Ortega, M, Sureda, A, Arnán, M, Valacárcel, D

Get full text

The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia by Díaz-Beyá, M, Brunet, S, Nomdedéu, J, Cordeiro, A, Tormo, M, Escoda, L, Ribera, J M, Arnan, M, Heras, I, Gallardo, D, Bargay, J, Queipo de Llano, M P, Salamero, O, Martí, J M, Sampol, A, Pedro, C, Hoyos, M, Pratcorona, M, Castellano, J J, Nomdedeu, M, Risueño, R M, Sierra, J, Monzó, M, Navarro, A, Esteve, J

“…Acute myeloid leukemia (AML) is a heterogeneous disease whose prognosis is mainly related to the biological risk conferred by cytogenetics and molecular…”
Get full text

BAALC -associated miR-3151 is an Independent Prognostic Factor in Young Patients With Intermediate-Risk Cytogenetic Acute Myeloid Leukemia by Díaz-Beyá, M, Navarro, A, Pratcorona, M, Brunet, S, Nomdedéu, J, Ribera, J.M, Tormo, M, Duarte, R, Salamero, O, Gallardo, D, Escoda, L, Nomdedeu, M, Risueño, R.M, Cervantes, F, Sierra, J, Monzó, M, Esteve, J

Get full text

MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy by Valera, Alexandra, López-Guillermo, Armando, Cardesa-Salzmann, Teresa, Climent, Fina, González-Barca, Eva, Mercadal, Santiago, Espinosa, Iñigo, Novelli, Silvana, Briones, Javier, Mate, José L, Salamero, Olga, Sancho, Juan M, Arenillas, Leonor, Serrano, Sergi, Erill, Nadina, Martínez, Daniel, Castillo, Paola, Rovira, Jordina, Martínez, Antonio, Campo, Elias, Colomo, Luis

“…MYC alterations influence the survival of patients with diffuse large B-cell lymphoma. Most studies have focused on MYC translocations but there is little…”
Get full text

Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation/inflammation: BONE MARROW CYTOKINES AND CHEMOKINES CONCENTRATIONS IN MYELODISPLASTIC NEOPLASMS by Yordi, A. Molero, Medina, D., Navarro, V., Montoro, M.J., González, A. Pérez, Saumell, S., Gallur, L., Tazón-Vega, B., Solas, T. Jiménez, López-Cadenas, F., Ezponda, T., Alfonso, A., Salamero, O., Diez-Campelo, M., Prosper, F., Valcárcel, D.

Get full text

Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation/inflammation: BONE MARROW MICROENVIRONMENT CHANGES IN MYELODYSPLASTIC NEOPLASMS AND ITS RELATIONSHIP WITH CLONAL HEMATOPOIESIS by Yordi, A. Molero, Gallur, L., Tazón-Vega, B., Navarro, V., Saumell, S., Montoro, M.J., Salamero, O., González, A. Pérez, Solas, T. Jiménez, López-Cadenas, F., Ezponda, T., Alfonso, A., Altimiras, L., Diez-Campelo, M., Prosper, F., Valcárcel, D.

Get full text

Topic: AS07-Singular Entities/Subtypes/AS07a-ARCH, CCUS, ICUS: PREVALENCE, DYNAMICS AND CLINICAL SIGNIFICANCE OF CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IN NEWLY DIAGNOSED CANCER PATIENTS by González, A. Pérez, Peralta-Garzón, S., Palomo, L., Navarro, V., Yordi, A. Molero, Tazón-Vega, B., Calvete, O., Salamero, O., Saumell, S., Rivero, E., Zamora, E., Saoudi, N., Fariñas, L., Torres-Esquius, S., Novoa, S., Garrido, S., Sola, M., Campelo, M., Alfonso, A., Montoro, M.J., Valcárcel, D.

Get full text

Topic: AS07-Singular Entities/Subtypes/AS07a-ARCH, CCUS, ICUS: CLINICAL AND CARDIOVASCULAR RISK ASSESSMENT OF SUBJECTS WITH JAK2-V617F CLONAL HEMATOPOIESIS by Garrido, S., López-Cadenas, F., García-Ávila, S., Tazón-Vega, B., Blanco, A., Palomo, L., Piris-Villaespesa, M., García-Gutiérrez, V., De Vilar, M., Sola, M., Yordi, A. Molero, González, A. Pérez, Restrepo, J., Fox, L., Saumell, S., Novoa, S., Gallur, L., Salamero, O., Oristrell, G., Castellví, J., Valcárcel, D., Montoro, M.J.

Get full text

Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation by Molero, A., Gallur, L., Tazón-Vega, B., Saumell, S., Solas, T. Jiménez, Ezponda, T., Montoro, J., Sánchez-Ruiz, C., López, F., Alfonso, A., Salamero, O., Ortega, M., Perez, A., Peralta, S., Díez-Campelo, M., Prosper, F., Bosch, F., Valcárcel, D.

Get full text

P31 - Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation: PHENOTYPE AND GENOTYPE OF NATURAL KILLERS IN MYELODISPLASITIC SYNDROME by Molero, A., Gallur, L., Tazón-Vega, B., Saumell, S., Solas, T. Jiménez, Ezponda, T., Montoro, J., Sánchez-Ruiz, C., López, F., Alfonso, A., Salamero, O., Ortega, M., Perez, A., Peralta, S., Díez-Campelo, M., Prosper, F., Bosch, F., Valcárcel, D.

Get full text

P30 - Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation: RELATION BETWEEN INMUNE CELL POPULATIONS AND MALIGNANT CLONE MUTATIONAL STATUS IN MYELODYSPLASTIC SYNDROMES by Molero, A., Tazón-Vega, B., Gallur, L., Saumell, S., Solas, T. Jiménez, Ezponda, T., López, F., Altimiras, L., Montoro, J., Sánchez-Ruiz, C., Alfonso, A., Salamero, O., Ortega, M., Perez, A., Peralta, S., Díez-Campelo, M., Prosper, F., Bosch, F., Valcárcel, D.

Get full text

Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation by Molero, A., Tazón-Vega, B., Gallur, L., Saumell, S., Solas, T. Jiménez, Ezponda, T., López, F., Altimiras, L., Montoro, J., Sánchez-Ruiz, C., Alfonso, A., Salamero, O., Ortega, M., Perez, A., Peralta, S., Díez-Campelo, M., Prosper, F., Bosch, F., Valcárcel, D.

Get full text